Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1
暂无分享,去创建一个
Tongyi Dou | Guangbo Ge | Ling Yang | J. Hou | Wei-Dong Zhang | Ping Wang | Zi-miao Weng | Dan-Dan Wang | Li-Wei Zou | Yiming Fan | Wei Lei
[1] Tongyi Dou,et al. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases , 2017, Toxicology and applied pharmacology.
[2] Guangbo Ge,et al. Recent progress in the discovery of natural inhibitors against human carboxylesterases. , 2017, Fitoterapia.
[3] Guangbo Ge,et al. Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark. , 2016, Fitoterapia.
[4] Tiangang Li,et al. Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1* , 2016, The Journal of Biological Chemistry.
[5] Guangbo Ge,et al. A highly selective near-infrared fluorescent probe for carboxylesterase 2 and its bioimaging applications in living cells and animals. , 2016, Biosensors & bioelectronics.
[6] Y. Zhu,et al. Human UDP‐Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol , 2016, Basic & clinical pharmacology & toxicology.
[7] Guangbo Ge,et al. Inhibition behavior of fructus psoraleae’s ingredients towards human carboxylesterase 1 (hCES1) , 2016, Xenobiotica; the fate of foreign compounds in biological systems.
[8] Guangbo Ge,et al. Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2. , 2016, European journal of medicinal chemistry.
[9] Dong Liu,et al. Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review , 2016, European Journal of Drug Metabolism and Pharmacokinetics.
[10] K. Chibale,et al. Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors , 2016, Xenobiotica; the fate of foreign compounds in biological systems.
[11] Guangbo Ge,et al. A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples. , 2016, Chemical communications.
[12] B. Shen. A New Golden Age of Natural Products Drug Discovery , 2015, Cell.
[13] Guangbo Ge,et al. Identification and characterization of naturally occurring inhibitors against UDP-glucuronosyltransferase 1A1 in Fructus Psoraleae (Bu-gu-zhi). , 2015, Toxicology and applied pharmacology.
[14] Guangbo Ge,et al. Protostane Triterpenoids from the Rhizome of Alisma orientale Exhibit Inhibitory Effects on Human Carboxylesterase 2. , 2015, Journal of natural products.
[15] Guangbo Ge,et al. Diethylstilbestrol can effectively accelerate estradiol-17-O-glucuronidation, while potently inhibiting estradiol-3-O-glucuronidation. , 2015, Toxicology and applied pharmacology.
[16] Guangbo Ge,et al. Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2. , 2015, Fitoterapia.
[17] Guangbo Ge,et al. A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1. , 2014, Biosensors & bioelectronics.
[18] A. Russell,et al. Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes , 2013, Nature chemical biology.
[19] W. Folk,et al. 21st century natural product research and drug development and traditional medicines. , 2013, Natural product reports.
[20] P. Potter,et al. Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen"). , 2013, Journal of natural products.
[21] Y. Kobayashi,et al. Contributions of Arylacetamide Deacetylase and Carboxylesterase 2 to Flutamide Hydrolysis in Human Liver , 2012, Drug Metabolism and Disposition.
[22] Yuichiro Sato,et al. Conclusive Identification of the Oxybutynin-Hydrolyzing Enzyme in Human Liver , 2012, Drug Metabolism and Disposition.
[23] K. Mlinarić-Majerski,et al. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis. , 2012, Bioorganic & medicinal chemistry.
[24] B. Cravatt,et al. The pharmacological landscape and therapeutic potential of serine hydrolases , 2012, Nature Reviews Drug Discovery.
[25] S. Laizure,et al. Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism , 2012, Analytical and Bioanalytical Chemistry.
[26] P. Potter,et al. Carboxylesterase inhibitors , 2011, Expert opinion on therapeutic patents.
[27] Hongbin Sun,et al. Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases. , 2011, Natural product reports.
[28] J. Vederas,et al. [Drug discovery and natural products: end of era or an endless frontier?]. , 2011, Biomeditsinskaia khimiia.
[29] M. Miura,et al. Involvement of Carboxylesterase 1 and 2 in the Hydrolysis of Mycophenolate Mofetil , 2010, Drug Metabolism and Disposition.
[30] Julie A. Johnson,et al. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril. , 2009, Biochemical pharmacology.
[31] P. Potter,et al. Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. , 2008, Biochimica et biophysica acta.
[32] Masakiyo Hosokawa,et al. Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs , 2008, Molecules.
[33] F. Akhlaghi,et al. Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel , 2006, Journal of Pharmacology and Experimental Therapeutics.
[34] Jian Yang,et al. Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol , 2006, Journal of Pharmacology and Experimental Therapeutics.
[35] Teruko Imai,et al. Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.
[36] T. Nyrönen,et al. Docking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands. , 2006, Journal of medicinal chemistry.
[37] Teruko Imai,et al. Human carboxylesterase isozymes: catalytic properties and rational drug design. , 2006, Drug metabolism and pharmacokinetics.
[38] M. Redinbo,et al. Mammalian carboxylesterases: from drug targets to protein therapeutics. , 2005, Drug discovery today.
[39] D. Murry,et al. Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[40] O. Cummings,et al. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] Charles L. Brooks,et al. Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..
[42] D. Vance,et al. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] Matthew R. Redinbo,et al. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme , 2003, Nature Structural Biology.
[44] H. McLeod,et al. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] P. Taylor,et al. Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[46] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.